By Christopher Geissler, Ph.D.
Applications for the 2022–2023 Emerging Research Grants (ERG) cycle open today, Monday, October 18, 2021.
Through the ERG program, Hearing Health Foundation (HHF) provides seed money to researchers working across the entire spectrum of hearing research and balance research, including many underfunded areas of otology. The ERG program has since 1958 played a foundational role in the careers of many academic researchers and clinicians in otolaryngology and related hearing and balance fields. As the program’s remit is so broad, please see the Call for Applications online for more details.
A 2019 ERG scientist, Victor Wong, Ph.D., is a postdoctoral fellow at the Burke Neurological Institute, Weill Cornell Medicine.
APPLICATIONS OPEN
October 18, 2021
APPLICATION DEADLINE
February 25, 2022
FUNDING
Up to $50,000 per year for each project for an initial period of one year, renewable for one additional year.
PROGRAM DATE
October 1, 2022–September 30, 2023
FUNDING DECISION NOTIFICATION
First week of August 2022
GRANT PAYMENT SCHEDULE
October 2022 and April 2023
The ERG program is a competitive process that awards grants to only the most promising investigators. Recipients are exceptionally well-positioned to win funding from the National Institutes of Health (NIH) and other major federal funders, leading to dramatic innovations in the field. In fact, ERG awardees (2002–present) have gone on to be awarded an average of $47 in federal research funding for every dollar of their ERG grant.
Early career researchers are especially encouraged to apply. Senior investigators are invited to apply for certain ERG grant opportunities – please see the Call for Applications for more details.
Christopher Geissler, Ph.D., is HHF’s director of program and research support. Apply for an Emerging Research Grant at hhf.org/how-to-apply. Learn more about ERGs at hhf.org/erg.
The Latest Blog Posts
Our results suggest that mature cochlear supporting cells can be reprogrammed into sensory hair cells, providing a possible target for hair cell regeneration in mammals.